| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |